[Skip to Content]
Sign In
Individual Sign In
Create an Account
Institutional Sign In
OpenAthens Shibboleth
[Skip to Content Landing]
Correction
October 2017

Error in Abstract

JAMA Neurol. 2017;74(10):1271. doi:10.1001/jamaneurol.2017.3044

In the Original Investigation titled “Neurological Complications Associated With Anti–Programmed Death 1 (PD-1) Antibodies,”1 published online September 5, 2017, there was an error in the Abstract. In the Results section of the Abstract, the sentence “Treatment with anti–PD-1 antibodies was discontinued in all patients” should have read “in 7 patients.” This article was corrected online.

References
1.
Kao  JC, Liao  B, Markovic  SN,  et al.  Neurological complications associated with anti–programmed death 1 (PD-1) antibodies [published online September 5, 2017].  JAMA Neurol. doi:10.1001/jamaneurol.2017.1912Google Scholar
×